<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK425540" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK425540/" /><meta name="ncbi_pagename" content="FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/04/06" /><meta name="citation_author" content="Mohammed Almannai" /><meta name="citation_author" content="Hongzheng Dai" /><meta name="citation_author" content="Ayman W El-Hattab" /><meta name="citation_author" content="Lee-Jun C Wong" /><meta name="citation_pmid" content="28383868" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK425540/" /><meta name="citation_keywords" content="FBXL4 Deficiency" /><meta name="citation_keywords" content="FBXL4-Related Early-Onset Mitochondrial Encephalopathy" /><meta name="citation_keywords" content="Mitochondrial DNA Depletion Syndrome 13 (MTDPS13), Encephalomyopathic Type" /><meta name="citation_keywords" content="Mitochondrial DNA Depletion Syndrome 13 (MTDPS13), Encephalomyopathic Type" /><meta name="citation_keywords" content="FBXL4 Deficiency" /><meta name="citation_keywords" content="FBXL4-Related Early-Onset Mitochondrial Encephalopathy" /><meta name="citation_keywords" content="F-box/LRR-repeat protein 4" /><meta name="citation_keywords" content="FBXL4" /><meta name="citation_keywords" content="FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Mohammed Almannai" /><meta name="DC.Contributor" content="Hongzheng Dai" /><meta name="DC.Contributor" content="Ayman W El-Hattab" /><meta name="DC.Contributor" content="Lee-Jun C Wong" /><meta name="DC.Date" content="2017/04/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK425540/" /><meta name="description" content="FBXL4-related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome is a multi-system disorder characterized primarily by congenital or early-onset lactic acidosis and growth failure, feeding difficulty, hypotonia, and developmental delay. Other neurologic manifestations can include seizures, movement disorders, ataxia, autonomic dysfunction, and stroke-like episodes. All affected individuals alive at the time they were reported (median age: 3.5 years) demonstrated significant developmental delay. Other findings can involve the heart (hypertrophic cardiomyopathy, congenital heart malformations, arrhythmias), liver (mildly elevated transaminases), eyes (cataract, strabismus, nystagmus, optic atrophy), hearing (sensorineural hearing loss), and bone marrow (neutropenia, lymphopenia). Survival varies; the median age of reported deaths was two years (range 2 days - 75 months), although surviving individuals as old as 36 years have been reported. To date FBXL4-related mtDNA depletion syndrome has been reported in 50 individuals." /><meta name="og:title" content="FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="FBXL4-related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome is a multi-system disorder characterized primarily by congenital or early-onset lactic acidosis and growth failure, feeding difficulty, hypotonia, and developmental delay. Other neurologic manifestations can include seizures, movement disorders, ataxia, autonomic dysfunction, and stroke-like episodes. All affected individuals alive at the time they were reported (median age: 3.5 years) demonstrated significant developmental delay. Other findings can involve the heart (hypertrophic cardiomyopathy, congenital heart malformations, arrhythmias), liver (mildly elevated transaminases), eyes (cataract, strabismus, nystagmus, optic atrophy), hearing (sensorineural hearing loss), and bone marrow (neutropenia, lymphopenia). Survival varies; the median age of reported deaths was two years (range 2 days - 75 months), although surviving individuals as old as 36 years have been reported. To date FBXL4-related mtDNA depletion syndrome has been reported in 50 individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK425540/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fbxl4-mtddepl/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK425540/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89EB14E041972100000000085203D9.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK425540_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK425540_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fbln5-cutis-laxa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/craniosynostosis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK425540_"><span class="title" itemprop="name"><i>FBXL4</i>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: FBXL4 Deficiency; <i>FBXL4</i>-Related Early-Onset Mitochondrial Encephalopathy; Mitochondrial DNA Depletion Syndrome 13 (MTDPS13), Encephalomyopathic Type</div><p class="contrib-group"><span itemprop="author">Mohammed Almannai</span>, MD, FAAP, FACMG, <span itemprop="author">Hongzheng Dai</span>, PhD, <span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG, and <span itemprop="author">Lee-Jun C Wong</span>, PhD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK425540_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK425540_ai__"><div class="contrib half_rhythm"><span itemprop="author">Mohammed Almannai</span>, MD, FAAP, FACMG<div class="affiliation small">Medical Genetics and Metabolic Consultant, Section of Medical Genetics<br />King Fahad Medical City<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.dem.cmfk@iannamlam" class="oemail">as.dem.cmfk@iannamlam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hongzheng Dai</span>, PhD<div class="affiliation small">Clinical Molecular Genetics and Genomics Fellow, Department of Molecular &#x00026; Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@iad.gnehzgnoh" class="oemail">ude.mcb@iad.gnehzgnoh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ayman W El-Hattab</span>, MD, FAAP, FACMG<div class="affiliation small">Associate Professor, Department of Clinical Sciences<br />College of Medicine<br />University of Sharjah<br />Sharjah, United Arab Emirates<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@wabattahle" class="oemail">moc.oohay@wabattahle</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lee-Jun C Wong</span>, PhD, FACMG<div class="affiliation small">Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@gnowjl" class="oemail">ude.mcb@gnowjl</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 6, 2017</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fbxl4-mtddepl.Summary" itemprop="description"><h2 id="_fbxl4-mtddepl_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>FBXL4</i>-related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome is a multi-system disorder characterized primarily by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or early-onset lactic acidosis and growth failure, feeding difficulty, hypotonia, and developmental delay. Other neurologic manifestations can include seizures, movement disorders, ataxia, autonomic dysfunction, and stroke-like episodes. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals alive at the time they were reported (median age: 3.5 years) demonstrated significant developmental delay. Other findings can involve the heart (hypertrophic cardiomyopathy, congenital heart malformations, arrhythmias), liver (mildly elevated transaminases), eyes (cataract, strabismus, nystagmus, optic atrophy), hearing (sensorineural hearing loss), and bone marrow (neutropenia, lymphopenia). Survival varies; the median age of reported deaths was two years (range 2 days - 75 months), although surviving individuals as old as 36 years have been reported. To date <i>FBXL4</i>-related mtDNA depletion syndrome has been reported in 50 individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>FBXL4</i>-related mtDNA depletion syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FBXL4</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management is best provided by a multidisciplinary team including neurology, nutrition, clinical genetics/metabolism, and developmental pediatrics. Other specialties may be involved as needed. To date no definite treatment is available; thus, treatment is mainly supportive: assuring adequate nutrition and standard treatment of neurologic complications including developmental delay / intellectual disability, seizures, cardiac complications, eye involvement, and hearing loss. Administration of cofactors and antioxidants, used in mitochondrial disorders with (generally) limited evidence of benefit, may be considered.</p><p><i>Surveillance:</i> No surveillance guidelines have been published. The treating physician should decide about the frequency of follow up of eyes, hearing, heart, feeding difficulties, liver, neurologic complications, and neutropenia based on the patient's findings.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>FBXL4</i>-related mtDNA depletion syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. When both parents are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (<a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>), and a 25% chance of being unaffected and not a carrier. Once the <i>FBXL4</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="fbxl4-mtddepl.Diagnosis"><h2 id="_fbxl4-mtddepl_Diagnosis_">Diagnosis</h2><div id="fbxl4-mtddepl.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>FBXL4</i>-related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome <b>should be suspected</b> in individuals with early-onset (often <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>) lactic acidosis along with a combination of the following clinical features, brain MRI findings, and supportive laboratory findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Developmental delay. Often global with severe speech impairment and lack of ambulation</div></li><li class="half_rhythm"><div>Neurologic findings, Hypotonia, seizures, movement disorders, such as ataxia, autonomic dysfunction</div></li><li class="half_rhythm"><div>Feeding difficulty and failure to thrive</div></li><li class="half_rhythm"><div>Abnormal growth. Intrauterine growth restriction, short stature, microcephaly (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and acquired)</div></li><li class="half_rhythm"><div>Cardiovascular abnormalities. Hypertrophic cardiomyopathy, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart malformations, arrhythmia, pulmonary hypertension</div></li></ul><p><b>Brain MRI findings</b></p><ul><li class="half_rhythm"><div>White matter abnormalities (19/32 individuals reported). T<sub>2</sub>-weighted hyperintensities, delayed or poor myelination, and leukodystrophic changes</div></li><li class="half_rhythm"><div>Cerebral atrophy (14/32). Progressive; could be evident as early as age three months [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>]</div></li><li class="half_rhythm"><div>Basal ganglia abnormalities, including lesions and abnormal signal intensities (11/32)</div></li><li class="half_rhythm"><div>Pervientricular cysts (9/32)</div></li><li class="half_rhythm"><div>Thin corpus callosum (6/32)</div></li><li class="half_rhythm"><div>Cerebellar hypoplasia (6/32)</div></li><li class="half_rhythm"><div>Arachnoid cysts (4/32)</div></li><li class="half_rhythm"><div>Brain stem atrophy (4/32)</div></li><li class="half_rhythm"><div>Stroke-like episodes (1/32) [<a class="bk_pop" href="#fbxl4-mtddepl.REF.ebrahimifakhari.2015.549">Ebrahimi-Fakhari et al 2015</a>]</div></li></ul><p>Only one child (who died at age 20 months) was reported to have a normal brain MRI [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>].</p><p>MR spectroscopy may show high lactate peak in the brain and cerebrospinal fluid [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</p><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Persistently elevated lactate levels (range: 3-21 mmol/L; median: 13 mmol/L) were observed in all individuals. When assayed, cerebrospinal fluid lactate levels were also elevated [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</div></li><li class="half_rhythm"><div>Hyperammonemia is seen in about 50% of individuals. Although ammonia levels close to 500 &#x003bc;mol/L have been reported [<a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>], the mean level was 141 &#x003bc;mol/L, median level 99 &#x003bc;mol/L, and range 30-485 &#x003bc;mol/L.</div></li><li class="half_rhythm"><div>Mild to moderate elevations in creatine kinase were reported in six of 13 individuals in one study [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</div></li><li class="half_rhythm"><div>Muscle tissue and skin fibroblasts show [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al 2017</a>]:</div><ul><li class="half_rhythm"><div>Variably reduced mtDNA content (range: 10%-70%; mean: ~30% of tissue- and age-matched controls); and</div></li><li class="half_rhythm"><div>Decreased activity of multiple complexes on electron transport chain activity assay in 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. There is usually combined, though variable, deficiency of all complexes.</div></li></ul></li><li class="half_rhythm"><div>Muscle histology can show fiber size variability, lipid and glycogen accumulation, and variable reduction in COX activity. Enlarged and structurally altered mitochondria can be seen on electron microscopy [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</div></li></ul></div><div id="fbxl4-mtddepl.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>FBXL4</i>-related mtDNA depletion syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FBXL4</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK425540/table/fbxl4-mtddepl.T.molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figfbxl4mtddeplTmoleculargenetictestin" rid-ob="figobfbxl4mtddeplTmoleculargenetictestin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Children with the suggestive clinical, laboratory, and neuroimaging findings could be diagnosed using gene-targeted testing (see <a href="#fbxl4-mtddepl.Option_1">Option 1</a>), whereas those with clinical features indistinguishable from many other mitochondrial disorders are more likely to be diagnosed using genomic testing (see <a href="#fbxl4-mtddepl.Option_2">Option 2</a>).</p><div id="fbxl4-mtddepl.Option_1"><h4>Option 1</h4><p>When the clinical, laboratory, and brain MRI findings suggest the diagnosis of <i>FBXL4</i>-related mtDNA depletion syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FBXL4</i> is performed first. If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered; however, to date no <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions have been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FBXL4</i> and other genes related to mtDNA depletion syndromes (see <a href="#fbxl4-mtddepl.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Of note, given the rarity of <i>FBXL4</i>-related mtDNA depletion syndrome some panels for mtDNA depletion syndromes may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="fbxl4-mtddepl.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other mitochondrial disorders <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) or <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> [<a class="bk_pop" href="#fbxl4-mtddepl.REF.wortmann.2015.437">Wortmann et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>].</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> for inherited mitochondrial disorders may also be considered.</div></li></ul><div id="fbxl4-mtddepl.T.molecular_genetic_testin" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FBXL4</i>-Related mtDNA Depletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.molecular_genetic_testin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.molecular_genetic_testin_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBXL4</i></td><td headers="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50/50&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_fbxl4-mtddepl.T.molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported to date</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fbxl4-mtddepl.TF.1.1"><p class="no_margin">See <a href="/books/NBK425540/#fbxl4-mtddepl.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="fbxl4-mtddepl.TF.1.2"><p class="no_margin">See <a href="#fbxl4-mtddepl.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="fbxl4-mtddepl.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="fbxl4-mtddepl.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al [2013]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al [2013]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al [2015]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al [2016]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al [2016]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al [2016]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.van_rij.2016.425">van Rij et al [2016]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al [2017]</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="fbxl4-mtddepl.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="fbxl4-mtddepl.Clinical_Characteristics"><h2 id="_fbxl4-mtddepl_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fbxl4-mtddepl.Clinical_Description"><h3>Clinical Description</h3><p><i>FBXL4</i>-related mtDNA depletion syndrome has been reported in 50 individuals to date [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.van_rij.2016.425">van Rij et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al 2017</a>]. It mainly presents as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lactic acidosis along with developmental delay, other neurologic manifestations, feeding difficulty, growth failure, and variable involvement of other organs.</p><p><b>Age of onset</b> was soon after birth in the majority of reported individuals (median age of onset: one day; range 1 day - 13 years). Only five individuals presented after age six months, including a female presenting at age 13 years [<a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>].</p><p>In two children, the disease presented prenatally: one male was born at 26 weeks' gestation following preterm labor resulting from polyhydramnios that was believed to be due to hypotonia and decreased fetal movement [<a class="bk_pop" href="#fbxl4-mtddepl.REF.van_rij.2016.425">van Rij et al 2016</a>]; another male was delivered at 34 weeks' gestation due to prenatally diagnosed supraventricular tachycardia [<a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</p><p>The common clinical manifestations summarized in <a class="figpopup" href="/books/NBK425540/table/fbxl4-mtddepl.T.clinical_manifestations/?report=objectonly" target="object" rid-figpopup="figfbxl4mtddeplTclinicalmanifestations" rid-ob="figobfbxl4mtddeplTclinicalmanifestations">Table 2</a> are discussed below the table.</p><div id="fbxl4-mtddepl.T.clinical_manifestations" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Clinical Manifestations of <i>FBXL4</i>-Related Mitochondrial DNA Depletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.clinical_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.clinical_manifestations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Manifestation</th><th id="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>50/50 (100%)</b></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Movement disorders&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Autonomic dysfunction</div></li><li class="half_rhythm"><div>Stroke-like episodes</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>45/45 (100%)</div></li><li class="half_rhythm"><div>39/42 (93%)</div></li><li class="half_rhythm"><div>14/42 (33%)</div></li><li class="half_rhythm"><div>5/17 (29%)</div></li><li class="half_rhythm"><div>4/15 (27%)</div></li><li class="half_rhythm"><div>3/12 (25%)</div></li><li class="half_rhythm"><div>1/32 (3%)</div></li></ul>
</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Microcephaly (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> &#x00026; acquired)</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>25/33 (76%)</div></li><li class="half_rhythm"><div>18/31 (58%)</div></li><li class="half_rhythm"><div>17/31 (55%)</div></li><li class="half_rhythm"><div>14/36 (39%)</div></li></ul>
</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Hepatopathy</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>27/31 (87%)</div></li><li class="half_rhythm"><div>8/24 (33%)</div></li></ul>
</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>20/37 (54%)</b></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>Congenital heart malformations</div></li><li class="half_rhythm"><div>Arrhythmia</div></li><li class="half_rhythm"><div>Pulmonary hypertension</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>10/37 (27%)</div></li><li class="half_rhythm"><div>7/37 (19%)</div></li><li class="half_rhythm"><div>6/41 (15%)</div></li><li class="half_rhythm"><div>4/37 (11%)</div></li></ul>
</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>20/30 (67%)</b></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cataract</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>5/30 (17%)</div></li><li class="half_rhythm"><div>5/31 (16%)</div></li><li class="half_rhythm"><div>6/30 (20%)</div></li><li class="half_rhythm"><div>3/30 (10%)</div></li></ul>
</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neutropenia</div></li><li class="half_rhythm"><div>Hearing impairment</div></li></ul>
</td><td headers="hd_h_fbxl4-mtddepl.T.clinical_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>8/43 (19%)</div></li><li class="half_rhythm"><div>4/33 (12%)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">IUGR = intrauterine growth restriction, defined as birth weight &#x0003c;10<sup>th</sup> centile</p></div></dd><dt>1. </dt><dd><div id="fbxl4-mtddepl.TF.2.1"><p class="no_margin">Movement disorders reported include dystonia, choreoathetosis, hyperkinetic movements, and tremors [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>].</p></div></dd></dl></div></div></div><p><b>Neurologic.</b> Developmental delay is usually global, associated with severe speech impairment and lack of ambulation in the majority of reported cases. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals alive at the time they were reported (age range: 1 month - 36 years; median age: 3.5 years) demonstrated significant developmental delay [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</p><p>Hypotonia is severe and early onset, often presenting in the neonatal period.</p><p>Seizures started at age four months in one infant [<a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>]. Seizure types reported include complex partial seizures [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>] and absence and generalized seizures [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>].</p><p>Other less commonly reported neurologic manifestations for which clinical information is available include:</p><ul><li class="half_rhythm"><div>Movement disorders including hyperkinetic movements [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>], dystonia and choreoathetosis [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>], and tremors [<a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>];</div></li><li class="half_rhythm"><div>Recurrent stroke-like episodes starting at age ten years in a girl who was reported at age 13 years [<a class="bk_pop" href="#fbxl4-mtddepl.REF.ebrahimifakhari.2015.549">Ebrahimi-Fakhari et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</div></li></ul><p><b>Gastrointestinal manifestations.</b> Feeding difficulties are a major problem for most individuals with <i>FBXL4</i>-related mtDNA depletion syndrome. Factors contributing to the feeding difficulties include hypotonia, gastroesophageal reflux disease, frequent vomiting, and swallowing dysfunction. Recurrent aspiration was reported in six individuals [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>]. Many require nasogastric tube feeding or gastrostomy.</p><p>Hepatopathy manifests as mildly elevated transaminases. Liver failure has not been reported to date. Of note, one individual with baseline mild increases in transaminases experienced further increase in liver enzymes following initiation of a ketogenic diet (initiated due to initial suspicion of pyruvate dehydrogenase deficiency) [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>].</p><p><b>Cardiac.</b> Cardiomyopathy, the most common cardiac manifestation, is typically hypertrophic. Left ventricular non-compaction was reported in one individual [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</p><p>Congenital heart malformations include atrial septal defect, ventricular septal defect, patent foramen ovale, patent ductus arteriosus, tricuspid regurgitation, and tetralogy of Fallot (TOF). Other than TOF, the reported cardiac malformations are either relatively common or physiologic, bringing into question whether these are true associations or chance occurrences.</p><p>Arrhythmias include supraventricular tachycardia and Wolff-Parkinson-White syndrome [<a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</p><p><b>Ophthalmologic.</b> Cataract was <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> in three individuals [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</p><p>Other reported eye findings include nystagmus and optic atrophy [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al 2017</a>].</p><p><b>Immunologic.</b> Neutropenia was either episodic or persistent. Neutropenia appeared to predispose to infections and poor wound healing [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</p><p>One individual had lymphopenia and hypogammaglobulinemia in addition to neutropenia [<a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>].</p><p>Even without neutropenia, some individuals were prone to recurrent infections which in some cases resulted in metabolic decompensation and death [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>].</p><p><b>Distinctive facial features.</b> About 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have some variable distinctive facial features, including the following: thick eyebrows, short, upslanted palpebral fissures with epicanthus, broad nasal bridge, bulbous nasal tip, and smooth and long philtrum.</p><p><b>Less frequently reported manifestations</b></p><ul><li class="half_rhythm"><div>Respiratory distress, likely due to hypotonia and weak muscles, was reported in six individuals [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</div></li><li class="half_rhythm"><div>Sensorineural hearing impairment was reported in four individuals [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al 2017</a>].</div></li><li class="half_rhythm"><div>Other uncommon features include renal tubular acidosis (5 individuals), progressive scoliosis (2 individuals), non-specified exercise intolerance (4 individuals), and sleep dysfunction.</div></li><li class="half_rhythm"><div>Several males had hypospadias and/or cryptorchidism. One male had hypoplastic scrotum [<a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>].</div></li><li class="half_rhythm"><div>One individual developed exocrine pancreatic deficiency [<a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>].</div></li></ul><p><b>Prognosis.</b>
<i>FBXL4</i>-related mtDNA depletion syndrome is associated with a high rate of death in childhood: 43% (20 of 47) of reported children are deceased; seven died early in infancy. The median age of death was two years (range 2 days - 75 months). The 27 individuals alive at the time that they were reported ranged in age from one month to 36 years (median age: 3.5 years). Because of the small number of reported individuals, it is possible (indeed, likely) that the published literature is biased towards more severe cases and, thus, the full clinical spectrum (and prognosis) is yet to be appreciated.</p></div><div id="fbxl4-mtddepl.GenotypePhenotype_Correlat"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="fbxl4-mtddepl.Prevalence"><h3>Prevalence</h3><p><i>FBXL4</i>-related mtDNA depletion syndrome is rare; the exact prevalence is unknown.</p><p>To date, 50 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from different ethnic groups &#x02013; including Arabs, persons of northern European heritage, and Latin Americans/Hispanics &#x02013; have been reported [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.van_rij.2016.425">van Rij et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.morton.2017.7">Morton et al 2017</a>].</p><p>Consanguinity was reported in 64% of cases.</p></div></div><div id="fbxl4-mtddepl.Genetically_Related_Alleli"><h2 id="_fbxl4-mtddepl_Genetically_Related_Alleli_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>FBXL4</i>.</p></div><div id="fbxl4-mtddepl.Differential_Diagnosis"><h2 id="_fbxl4-mtddepl_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>FBXL4</i>-related mtDNA depletion syndrome needs to be differentiated from other mtDNA depletion syndromes, a genetically and clinically heterogeneous group of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> tissues and organs.</p><p>Mitochondrial DNA depletion syndromes occur as a result of defects in mtDNA maintenance caused by pathogenic variants in nuclear genes that function in either mitochondrial nucleotide synthesis (e.g., <i>TK2</i>, <i>SUCLA2</i>, <i>SUCLG1</i>, <i>RRM2B</i>, <i>DGUOK</i>, and <i>TYMP</i>) or mtDNA replication (e.g., <i>POLG</i> and <i>TWNK</i>). The function of <i>FBXL4</i> is not yet known.</p><p>Mitochondrial DNA depletion syndromes are phenotypically classified into myopathic, encephalomyopathic, hepatocerebral, and neurogastrointestinal forms (<a class="figpopup" href="/books/NBK425540/table/fbxl4-mtddepl.T.mitochondrial_dna_deplet/?report=objectonly" target="object" rid-figpopup="figfbxl4mtddeplTmitochondrialdnadeplet" rid-ob="figobfbxl4mtddeplTmitochondrialdnadeplet">Table 3</a>) [<a class="bk_pop" href="#fbxl4-mtddepl.REF.elhattab.2013.186">El-Hattab &#x00026; Scaglia 2013</a>].</p><p><b>Myopathic forms</b> present in infancy or early childhood with hypotonia, proximal muscle weakness, and feeding difficulty. Cognition is usually spared. Typically, there is rapid progression of muscle weakness with respiratory failure and death within a few years of onset.</p><p><b>Encephalomyopathic mtDNA depletion syndromes</b> present in infancy with hypotonia and developmental delay. Depending on the underlying defect, other features, including deafness, movement disorders, Leigh like syndrome, and renal disease, can be observed.</p><p><b>Hepatocerebral forms</b> present with early-onset liver dysfunction and neurologic involvement, including developmental delay, abnormal eye movements, and peripheral neuropathy.</p><p><b>Neurogastrointestinal</b>
<b>forms,</b> the prototype of which is mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease, present in adolescence to early adulthood with progressive gastrointestinal dysmotility, cachexia, and peripheral neuropathy.</p><div id="fbxl4-mtddepl.T.mitochondrial_dna_deplet" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Mitochondrial DNA Depletion Syndromes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.mitochondrial_dna_deplet/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.mitochondrial_dna_deplet_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype&#x000a0;<sup>1</sup></th><th id="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial DNA Depletion Syndrome #, Type</th><th id="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Hepato-<br />cerebral</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DGUOK</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3, hepatocerebral type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dguok-mtddepl/">Deoxyguanosine Kinase Deficiency</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4A, Alpers type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>MPV17</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6<i>,</i> hepatocerebral type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mpv17-mtdep/"><i>MPV17</i>-Related Hepatocerebral Mitochondrial DNA Depletion Syndrome</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TWNK</i> (<i>C10orf2)</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7, hepatocerebral type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/271245" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">271245</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TFAM</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15, hepatocerebral type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/617156" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617156</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Encephalo-<br />myopathic</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLA2</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5, encephalomyopathic type w/methylmalonic aciduria</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FBXL4</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13, encephalomyopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBXL4</i>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SUCLG1</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9, encephalomyopathic type with methylmalonic aciduria</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8A, encephalomyopathic type w/renal tubulopathy</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>OPA1</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14, encephalocardiomyopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/616896" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616896</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ABAT</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Encephalomyopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/613163" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613163</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Neurogastro-<br />intestinal</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TYMP</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1, MNGIE type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mngie/">Mitochondrial Neurogastrointestinal Encephalopathy Disease</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4B, MNGIE type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8B, MNGIE type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TK2</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2, myopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tk2-mtddepl/"><i>TK2</i>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>AGK</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10, cardiomyopathic type (Sengers syndrome)</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/212350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">212350</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>MGME1</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11, myopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/615084" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615084</a></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A4</i></td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12B, cardiomyopathic type</td><td headers="hd_h_fbxl4-mtddepl.T.mitochondrial_dna_deplet_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/615418" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615418</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fbxl4-mtddepl.TF.3.1"><p class="no_margin">Within each phenotypic category, mtDNA depletion syndromes are ordered by relative prevalence.</p></div></dd><dt>2. </dt><dd><div id="fbxl4-mtddepl.TF.3.2"><p class="no_margin">See hyperlinked <i>GeneReview</i> or OMIM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> entry for more information.</p></div></dd></dl></div></div></div></div><div id="fbxl4-mtddepl.Management"><h2 id="_fbxl4-mtddepl_Management_">Management</h2><div id="fbxl4-mtddepl.Evaluations_Following_Init"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of the disease and needs in an individual diagnosed with <i>FBXL4</i>-related mtDNA depletion syndrome, the evaluations following diagnosis (if not performed as part of the evaluation that led to diagnosis) listed in <a class="figpopup" href="/books/NBK425540/table/fbxl4-mtddepl.T.recommended_evaluations/?report=objectonly" target="object" rid-figpopup="figfbxl4mtddeplTrecommendedevaluations" rid-ob="figobfbxl4mtddeplTrecommendedevaluations">Table 4</a> are recommended.</p><div id="fbxl4-mtddepl.T.recommended_evaluations" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.recommended_evaluations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.recommended_evaluations_lrgtbl__"><table><thead><tr><th id="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing assessment</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac evaluation w/electrocardiogram &#x00026; echocardiography</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a cardiologist if results are abnormal.</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nutritional evaluation; swallowing assessment for feeding difficulties</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Evaluation of liver function w/AST/ALT, bilirubin, total protein, albumin, &#x00026; coagulation profile</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurology consultation including comprehensive neurologic examination</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Brain MRI to evaluate extent of disease</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Electroencephalogram</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If there is a history of seizures</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immunologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count to evaluate for neutropenia</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider more detailed immunologic evaluation if there is a history of recurrent infections.</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental evaluation to provide baseline level of functioning &#x00026; recommendations for services (speech, occupational, &#x00026; physical therapy)</td><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_evaluations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a clinical geneticist &#x00026;/or genetic counselor</td></tr></tbody></table></div></div></div><div id="fbxl4-mtddepl.Treatment_of_Manifestation"><h3>Treatment of Manifestations</h3><p>Management is best provided by a multidisciplinary team including neurology, nutrition, clinical genetics / metabolism, and developmental pediatrics. Other specialties including gastroenterology, cardiology, hematology, immunology, ophthalmology, and nephrology may be involved based on the associated complications.</p><p>No definite treatment is available to date; thus, treatment is mainly supportive (<a class="figpopup" href="/books/NBK425540/table/fbxl4-mtddepl.T.treatment_of_manifestati/?report=objectonly" target="object" rid-figpopup="figfbxl4mtddeplTtreatmentofmanifestati" rid-ob="figobfbxl4mtddeplTtreatmentofmanifestati">Table 5</a>). Administration of cofactors and antioxidants, used in mitochondrial disorders with (generally) limited evidence of benefit, may be considered.</p><div id="fbxl4-mtddepl.T.treatment_of_manifestati" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>FBXL4</i>-related mtDNA depletion syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.treatment_of_manifestati/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.treatment_of_manifestati_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Inadequate nutrition</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A nasogastric tube or gastrostomy tube are frequently needed due to feeding difficulties &#x00026; failure to thrive.</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In 1 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child, improved nutrition resulted in improvement in hypogammaglobulinemia &#x00026; neutropenia.&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment w/antiepileptic drugs</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immobility/wheelchair dependence</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/physical medicine &#x00026; rehabilitation specialists to help w/mobility or assistive devices (e.g., wheelchair)</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiomyopathy &#x00026; arrhythmia</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per cardiologist recommendations</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neutropenia</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider granulocyte colony stimulating factor.&#x000a0;<sup>2</sup></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Significant acidosis</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider bicarbonate therapy.</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cataract &#x00026;/or strabismus</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical treatment if indicated</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing aids</td><td headers="hd_h_fbxl4-mtddepl.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fbxl4-mtddepl.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al [2016]</a></p></div></dd><dt>2. </dt><dd><div id="fbxl4-mtddepl.TF.5.2"><p class="no_margin"><a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al [2015]</a></p></div></dd></dl></div></div></div><div id="fbxl4-mtddepl.Developmental_Delay__Intel"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the United States, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="fbxl4-mtddepl.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function (e.g., feeding, grooming, dressing, and writing).</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy (typically from an occupational or speech therapist) is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a>) for individuals who have expressive language difficulties.</p></div></div><div id="fbxl4-mtddepl.Prevention_of_Secondary_Co"><h3>Prevention of Secondary Complications</h3><p>Regular immunization to prevent life-threatening infections is indicated.</p><p>Antibiotic prophylaxis may be indicated for those with immunodeficiency [<a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>].</p></div><div id="fbxl4-mtddepl.Surveillance"><h3>Surveillance</h3><p>No surveillance guidelines have been published. The following evaluations should be performed on a regular basis, with the treating physician determining the frequency based on initial presentation and severity of the condition.</p><div id="fbxl4-mtddepl.T.recommended_surveillance" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>FBXL4</i>-Related mtDNA Depletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.T.recommended_surveillance/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.T.recommended_surveillance_lrgtbl__"><table><thead><tr><th id="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th></tr></thead><tbody><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT/Mouth</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing evaluation</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram &#x00026; electrocardiogram to monitor for development of cardiomyopathy and/or arrhythmia, respectively</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Continued assessment of nutrition and growth</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Measurement of serum lactate, electrolytes, &#x00026; liver function tests w/AST/ALT, bilirubin, total protein, albumin, &#x00026; coagulation profile</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular neurologic evaluations &#x00026; developmental assessments</td></tr><tr><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Immunologic</b></td><td headers="hd_h_fbxl4-mtddepl.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count</td></tr></tbody></table></div></div></div><div id="fbxl4-mtddepl.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#fbxl4-mtddepl.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fbxl4-mtddepl.Therapies_Under_Investigat"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="fbxl4-mtddepl.Genetic_Counseling"><h2 id="_fbxl4-mtddepl_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fbxl4-mtddepl.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>FBXL4</i>-related mtDNA depletion syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="fbxl4-mtddepl.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are typically heterozygotes (i.e., carriers of one <i>FBXL4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In the (usual) instance in which both parents are carriers: at conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b>
<i>FBXL4</i>-related mtDNA depletion syndrome is typically lethal before reproductive age.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>FBXL4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="fbxl4-mtddepl.Carrier_Heterozygote_Detec"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>FBXL4</i> pathogenic variants in the family.</p></div><div id="fbxl4-mtddepl.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fbxl4-mtddepl.Prenatal_Testing_and_Preim"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FBXL4</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="fbxl4-mtddepl.Resources"><h2 id="_fbxl4-mtddepl_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="fbxl4-mtddepl.Molecular_Genetics"><h2 id="_fbxl4-mtddepl_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fbxl4-mtddepl.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26235" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FBXL4</i></a></td><td headers="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26235" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q16<wbr style="display:inline-block"></wbr>​.1-q16.2</a></td><td headers="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UKA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">F-box/LRR-repeat protein 4</a></td><td headers="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FBXL4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBXL4</a></td><td headers="hd_b_fbxl4-mtddepl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FBXL4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBXL4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fbxl4-mtddepl.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fbxl4-mtddepl.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome (<a href="/omim/605654,615471" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425540/table/fbxl4-mtddepl.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fbxl4-mtddepl.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605654" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605654</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4; FBXL4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615471" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615471</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>FBXL4</i> comprises nine exons and spans 79 kb. See <a href="/books/NBK425540/#fbxl4-mtddepl.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> About 50% of reported variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>; others include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and frame shift variants [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.huemer.2015.905">Huemer et al 2015</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.van_rij.2016.425">van Rij et al 2016</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.dai.2017.634">Dai et al 2017</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>FBXL4</i> encodes the F-box and leucine-rich repeat protein 4 (FBXL4) which localizes to the mitochondria via a mitochondrial targeting sequence [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>]. While the exact function of this protein is not known, it is believed to have an important role in mitochondrial maintenance. This is supported by findings in muscle tissue and/or skin fibroblasts from individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>FBXL4</i> pathogenic variants which showed decreased activity of multiple respiratory chain enzymes, disturbance of the mitochondrial network, loss of membrane potential, and variable depletion of mitochondrial DNA content [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.antoun.2016.1">Antoun et al 2016</a>]. Of note, these biochemical defects were rescued by introduction of wild type <i>FBXL4</i> [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>FBXL4</i> pathogenic variants result in loss of FBXL4 protein function, which in turn results in impaired mtDNA maintenance manifesting as mtDNA depletion and impaired energy production [<a class="bk_pop" href="#fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen et al 2013</a>, <a class="bk_pop" href="#fbxl4-mtddepl.REF.gai.2013.482">Gai et al 2013</a>].</p></div><div id="fbxl4-mtddepl.References"><h2 id="_fbxl4-mtddepl_References_">References</h2><div id="fbxl4-mtddepl.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.antoun.2016.1">Antoun G, McBride S, Vanstone JR, Naas T, Michaud J, Redpath S, McMillan HJ, Brophy J, Daoud H, Chakraborty P, Dyment D, Holcik M, Harper ME, Lines MA. Detailed biochemical and bioenergetic characterization of FBXL4-related encephalomyopathic mitochondrial DNA depletion. <span><span class="ref-journal">JIMD Rep. </span>2016;<span class="ref-vol">27</span>:1–9.</span> [<a href="/pmc/articles/PMC5580732/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5580732</span></a>] [<a href="/pubmed/26404457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26404457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.bonnen.2013.471">Bonnen PE, Yarham JW, Besse A, Wu P, Faqeih EA, Al-Asmari AM, Saleh MA, Eyaid W, Hadeel A, He L, Smith F, Yau S, Simcox EM, Miwa S, Donti T, Abu-Amero KK, Wong LJ, Craigen WJ, Graham BH, Scott KL, McFarland R, Taylor RW. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:471–81.</span> [<a href="/pmc/articles/PMC3769921/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3769921</span></a>] [<a href="/pubmed/23993193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23993193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.bar_y.2016.342">Bar&#x000f8;y T, Pedurupillay CR, Bliksrud YT, Rasmussen M, Holmgren A, Vigeland MD, Hughes T, Brink M, Rodenburg R, Nedregaard B, Str&#x000f8;mme P, Frengen E, Misceo D. A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13. <span><span class="ref-journal">Eur J Med Genet. </span>2016;<span class="ref-vol">59</span>:342–6.</span> [<a href="/pubmed/27182039" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27182039</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.dai.2017.634">Dai H, Zhang VW, El-Hattab AW, Ficicioglu C, Shinawi M, Lines M, Schulze A, McNutt M, Gotway G, Tian X, Chen S, Wang J, Craigen WJ, Wong LJ. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">91</span>:634–9.</span> [<a href="/pubmed/27743463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27743463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.ebrahimifakhari.2015.549">Ebrahimi-Fakhari D, Seitz A, K&#x000f6;lker S, Hoffmann GF. Recurrent stroke-like episodes in FBXL4-associated early-onset mitochondrial encephalomyopathy. <span><span class="ref-journal">Pediatr Neurol. </span>2015;<span class="ref-vol">53</span>:549–50.</span> [<a href="/pubmed/26421988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26421988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.elhattab.2013.186">El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. <span><span class="ref-journal">Neurotherapeutics. </span>2013;<span class="ref-vol">10</span>:186–98.</span> [<a href="/pmc/articles/PMC3625391/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3625391</span></a>] [<a href="/pubmed/23385875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23385875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.gai.2013.482">Gai X, Ghezzi D, Johnson MA, Biagosch CA, Shamseldin HE, Haack TB, Reyes A, Tsukikawa M, Sheldon CA, Srinivasan S, Gorza M, Kremer LS, Wieland T, Strom TM, Polyak E, Place E, Consugar M, Ostrovsky J, Vidoni S, Robinson AJ, Wong LJ, Sondheimer N, Salih MA, Al-Jishi E, Raab CP, Bean C, Furlan F, Parini R, Lamperti C, Mayr JA, Konstantopoulou V, Huemer M, Pierce EA, Meitinger T, Freisinger P, Sperl W, Prokisch H, Alkuraya FS, Falk MJ, Zeviani M. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:482–95.</span> [<a href="/pmc/articles/PMC3769923/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3769923</span></a>] [<a href="/pubmed/23993194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23993194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.huemer.2015.905">Huemer M, Karall D, Schossig A, Abdenur JE, Al Jasmi F, Biagosch C, Distelmaier F, Freisinger P, Graham BH, Haack TB, Hauser N, Hertecant J, Ebrahimi-Fakhari D, Konstantopoulou V, Leydiker K, Lourenco CM, Scholl-B&#x000fc;rgi S, Wilichowski E, Wolf NI, Wortmann SB, Taylor RW, Mayr JA, Bonnen PE, Sperl W, Prokisch H, McFarland R. Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015;<span class="ref-vol">38</span>:905–14.</span> [<a href="/pmc/articles/PMC4841446/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4841446</span></a>] [<a href="/pubmed/25868664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25868664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.morton.2017.7">Morton SU, Neilan EG, Peake RW, Shi J, Schmitz-Abe K, Towne M, Markianos K, Prabhu SP, Agrawal PB. Hyperammonemia as a presenting feature in two siblings with FBXL4 variants. <span><span class="ref-journal">JIMD Rep. </span>2017;<span class="ref-vol">35</span>:7–15.</span> [<a href="/pmc/articles/PMC5585110/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5585110</span></a>] [<a href="/pubmed/27858371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27858371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.pronicka.2016.174">Pronicka E, Piekutowska-Abramczuk D, Ciara E, Trubicka J, Rokicki D, Karkuci&#x00144;ska-Wi&#x00119;ckowska A, Pajdowska M, Jurkiewicz E, Halat P, Kosi&#x00144;ska J, Pollak A, Rydzanicz M, Stawinski P, Pronicki M, Krajewska-Walasek M, P&#x00142;oski R. New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre. <span><span class="ref-journal">J Transl Med. </span>2016;<span class="ref-vol">14</span>:174.</span> [<a href="/pmc/articles/PMC4903158/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4903158</span></a>] [<a href="/pubmed/27290639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27290639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.van_rij.2016.425">van Rij MC, Jansen FA, Hellebrekers DM, Onkenhout W, Smeets HJ, Hendrickx AT, Gottschalk RW, Steggerda SJ, Peeters-Scholte CM, Haak MC, Hilhorst-Hofstee Y. Polyhydramnios and cerebellar atrophy: a prenatal presentation of mitochondrial encephalomyopathy caused by mutations in the FBXL4 gene. <span><span class="ref-journal">Clin Case Rep. </span>2016;<span class="ref-vol">4</span>:425–8.</span> [<a href="/pmc/articles/PMC4831400/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4831400</span></a>] [<a href="/pubmed/27099744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27099744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fbxl4-mtddepl.REF.wortmann.2015.437">Wortmann SB, Koolen DA, Smeitink JA, van den Heuvel L, Rodenburg RJ. Whole exome sequencing of suspected mitochondrial patients in clinical practice. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015;<span class="ref-vol">38</span>:437–43.</span> [<a href="/pmc/articles/PMC4432107/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4432107</span></a>] [<a href="/pubmed/25735936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25735936</span></a>]</div></li></ul></div></div><div id="fbxl4-mtddepl.Chapter_Notes"><h2 id="_fbxl4-mtddepl_Chapter_Notes_">Chapter Notes</h2><div id="fbxl4-mtddepl.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 April 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>6 October 2016 (ma) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK425540</span><span class="label">PMID: <a href="/pubmed/28383868" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28383868</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fbln5-cutis-laxa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/craniosynostosis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK425540&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK425540/?report=reader">PubReader</a></li><li><a href="/books/NBK425540/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK425540" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK425540" style="display:none" title="Cite this Page"><div class="bk_tt">Almannai M, Dai H, El-Hattab AW, et al. FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome. 2017 Apr 6. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK425540/pdf/Bookshelf_NBK425540.pdf">PDF version of this page</a> (472K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fbxl4-mtddepl.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fbxl4-mtddepl.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fbxl4-mtddepl.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fbxl4-mtddepl.Genetically_Related_Alleli" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fbxl4-mtddepl.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fbxl4-mtddepl.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fbxl4-mtddepl.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fbxl4-mtddepl.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fbxl4-mtddepl.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fbxl4-mtddepl.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fbxl4-mtddepl.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26235[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FBXL4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4391774" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4391774" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4391774" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4391774" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28358460" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24741716" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gorman GS, Taylor RW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301762" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593919" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPV17-</i>Related Mitochondrial DNA Maintenance Defect</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPV17-</i>Related Mitochondrial DNA Maintenance Defect<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Wang J, Dai H, Almannai M, Scaglia F, Craigen WJ, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301403" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28383868" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28383868" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042962dde08911699dd1d2">FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome - GeneRevi...</a><div class="ralinkpop offscreen_noflow">FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:30:42-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89EB14E041972100000000085203D9&amp;ncbi_session=CE89EB14E0429611_2130SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK425540%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK425540&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK425540/&amp;ncbi_pagename=FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89EB14E0429611_2130SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>